1 |
Toyooka S, Suzuki M, Maruyama R, et al (2004). The relationship between aberrant methylation and survival in non-small-cell lung cancers. Br J Cancer, 91, 771-4.
DOI
|
2 |
Missaoui N, Hmissa S, Dante R, Frappart L, et al (2010). Global DNA methylation in precancerous and cancerous lesions of the uterine cervix. Asian Pac J Cancer Prev, 11, 1741-4.
|
3 |
Moison C, Senamaud-Beaufort C, Fourriere L, et al (2013). DNA methylation associated with polycomb repression in retinoic acid receptor silencing. FASEB J, 27, 1468-78.
DOI
ScienceOn
|
4 |
Virmani AK, Rathi A, Zochbauer-Muller S, et al (2000). Gazdar AF Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst, 92, 1303-7.
DOI
ScienceOn
|
5 |
Vo LT, Thuan TB, Thu DM, et al (2013). Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer. Asian Pac J Cancer Prev, 14, 7713-8.
과학기술학회마을
DOI
ScienceOn
|
6 |
Zochbauer-Muller S, Minna JD, Gazdar AF (2002). Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist, 7, 451-7.
DOI
ScienceOn
|
7 |
Zuo H, Chan AS, Ammer H, et al (2013). Activation of Gq subunits up-regulates the expression of the tumor suppressor Fhit. Cell Signal, 25, 2440-52.
DOI
ScienceOn
|
8 |
Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
DOI
ScienceOn
|
9 |
Fujiwara K, Fujimoto N, Tabata M, et al (2005). Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res, 11, 1219-25.
|
10 |
Grote HJ, Schmiemann V, Geddert H, et al (2006). Methylation of RAS association domain family protein 1A as a biomarker of lung cancer. Cancer, 108, 129-34.
DOI
ScienceOn
|
11 |
Hesson LB, Cooper WN, Latif F (2007). The role of RASSF1A methylation in cancer. Dis Markers, 23, 73-87.
DOI
|
12 |
Li W, Deng J, Jiang P, et al (2012). Methylation of the RASSF1A and RAR genes as a candidate biomarker for lung cancer. Exp Ther Med, 3, 1067-71.
DOI
|
13 |
Jeong YJ, Jeong HY, Lee SM, et al (2013). Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients. Oncol Rep, 30, 2270-8.
DOI
|
14 |
Ki KD, Lee SK, Tong SY, et al (2008). Role of 5'-CpG island hypermethylation of the FHIT gene in cervical carcinoma. J Gynecol Oncol, 19, 117-22.
DOI
ScienceOn
|
15 |
Ko E, Lee BB, Kim Y, Lee EJ, et al (2013). Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer. Clin Cancer Res, 19, 1204-12.
DOI
ScienceOn
|
16 |
Mengxi D, Qian W, Nan W, et al (2013). Effect of DNA methylation inhibitor on RASSF1A genes expression in non-small cell lung cancer cell line A549 and A549DDP. Cancer Cell Int, 13, 91.
DOI
ScienceOn
|
17 |
Chen X, Li P, Yang Z, et al (2013). Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 14, 165-71.
과학기술학회마을
DOI
ScienceOn
|
18 |
Al-Temaimi RA, Jacob S, Al-Ali W, et al (2013). Reduced FHIT expression is associated with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer. Histochem Cytochem, 61, 627-38.
DOI
ScienceOn
|
19 |
Bodoor K, Haddad Y, Alkhateeb A, et al (2014). DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev, 15, 75-84.
과학기술학회마을
DOI
ScienceOn
|
20 |
Botana-Rial M, De Chiara L, Valverde D, et al (2012). Prognostic value of aberrant hypermethylation in pleural effusion of lung adenocarcinoma. Cancer Biol Ther, 13, 1436-42 .
DOI
|
21 |
Deng YF, Zhang L, Zhang XQ, et al (2012). Methylation of FHIT gene promoter region in DNA from plasma of patients with myelodysplastic syndromes and demethylating effect of decitabine. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 20, 1144-8.
|
22 |
Dumitrescu RG (2012). Epigenetic markers of early tumor development. Methods Mol Biol, 863, 3-14.
DOI
ScienceOn
|
23 |
Fiolka R, Zubor P, Janusicova V, et al (2013). Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncol Rep, 30, 2878-86.
DOI
|
24 |
Liu WJ, Tan XH, Guo BP, et al (2013). Associations between RASSF1A promoter methylation and NSCLC: a meta-analysis of published data. Asian Pac J Cancer Prev, 14, 3719-24
과학기술학회마을
DOI
ScienceOn
|
25 |
Neyaz MK, Kumar RS, Hussain S, et al (2008). Effect of aberrant promoter methylation of FHIT and RASSF1A genes on sudceptibility to cervical cancer in a North Indian population, Biomarkers, 13, 597-606.
DOI
ScienceOn
|